Published in Pain on January 01, 1997
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N Engl J Med (2010) 6.34
Anti-GD(2) with an FC point mutation reduces complement fixation and decreases antibody-induced allodynia. Pain (2010) 1.38
Ligands Binding to Cell Surface Ganglioside GD2 Cause Src-Dependent Activation of N-Methyl-D-Aspartate Receptor Signaling and Changes in Cellular Morphology. PLoS One (2015) 0.75
Chimeric antibody c.8B6 to O-acetyl-GD2 mediates the same efficient anti-neuroblastoma effects as therapeutic ch14.18 antibody to GD2 without antibody induced allodynia. PLoS One (2014) 0.75
Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods (1994) 23.05
Analgesia mediated by a direct spinal action of narcotics. Science (1976) 2.84
Upregulation of dorsal root ganglion (alpha)2(delta) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. J Neurosci (2001) 2.33
Control of body temperature in the unanaesthetized monkey by cholinergic and aminergic systems in the hypothalamus. J Physiol (1969) 2.23
Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity. Pain (1996) 2.20
Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther (1992) 2.17
Studies on the direct spinal action of narcotics in the production of analgesia in the rat. J Pharmacol Exp Ther (1977) 2.11
Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo. Nature (1980) 2.08
Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science (1992) 2.00
Spinal opiate analgesia: characteristics and principles of action. Pain (1981) 1.97
Intrathecal somatostatin in cat and mouse studies on pain, motor behavior, and histopathology. Anesth Analg (1989) 1.96
Walking speed and stride length predicts 36 months dependency, mortality, and institutionalization in Chinese aged 70 and older. J Am Geriatr Soc (1999) 1.95
Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction. Anesthesiology (1993) 1.86
Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing. Pharmacol Biochem Behav (1985) 1.85
Prolonged alleviation of tactile allodynia by intravenous lidocaine in neuropathic rats. Anesthesiology (1995) 1.83
In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat. J Pharmacol Exp Ther (1984) 1.83
Characterization of variables defining hindpaw withdrawal latency evoked by radiant thermal stimuli. J Neurosci Methods (1997) 1.82
Studies in the primate on the analgetic effects associated with intrathecal actions of opiates, alpha-adrenergic agonists and baclofen. Anesthesiology (1981) 1.80
Neurogenic hyperalgesia: central neural correlates in responses of spinothalamic tract neurons. J Neurophysiol (1991) 1.72
High-risk mild head injury. J Neurosurg (1997) 1.66
Systematic examination in the rat of brain sites sensitive to the direct application of morphine: observation of differential effects within the periaqueductal gray. Brain Res (1976) 1.66
Release of substance P from the cat spinal cord. J Physiol (1987) 1.52
Thermoregulation around a new set-point' established in the monkey by altering the ratio of sodium to calcium ions within the hypothalamus. J Physiol (1971) 1.51
Long-term spinal analgesic delivery: a review of the preclinical and clinical literature. Reg Anesth Pain Med (2000) 1.51
Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat. J Pharmacol Exp Ther (1997) 1.50
Effect of a chimeric anti-ganglioside GD2 antibody on cell-mediated lysis of human neuroblastoma cells. Cancer Res (1991) 1.48
Effect of continuous spinal remifentanil infusion on behaviour and spinal glutamate release evoked by subcutaneous formalin in the rat. Br J Anaesth (1998) 1.45
Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia. J Pharmacol Exp Ther (1994) 1.44
Differential cross-tolerance between intrathecal morphine and sufentanil in the rat. Anesthesiology (1990) 1.42
Spinal cord pharmacology of adrenergic agonist-mediated antinociception. J Pharmacol Exp Ther (1980) 1.39
Narcotic analgestics: CNS sites and mechanisms of action as revealed by intracerebral injection techniques. Pain (1978) 1.37
The effect of spinal GABA receptor agonists on tactile allodynia in a surgically-induced neuropathic pain model in the rat. Pain (1997) 1.36
Effect of COX-1 and COX-2 inhibition on induction and maintenance of carrageenan-evoked thermal hyperalgesia in rats. J Pharmacol Exp Ther (1998) 1.36
Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin. Mayo Clin Proc (1981) 1.35
Nociceptive and inflammatory effects of subcutaneous TNFalpha. Pain (2000) 1.34
Voltage-sensitive calcium channels in spinal nociceptive processing: blockade of N- and P-type channels inhibits formalin-induced nociception. J Neurosci (1994) 1.34
Intrathecal capsaicin depletes substance P in the rat spinal cord and produces prolonged thermal analgesia. Science (1979) 1.33
The physiology and pharmacology of spinal opiates. Annu Rev Pharmacol Toxicol (1985) 1.31
Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine. Pain (1996) 1.27
Spinal nerve ligation induces transient upregulation of tumor necrosis factor receptors 1 and 2 in injured and adjacent uninjured dorsal root ganglia in the rat. Neurosci Lett (2003) 1.27
Cardiorespiratory and spinal cord blood flow effects of intrathecal neostigmine methylsulfate, clonidine, and their combination in sheep. Anesthesiology (1995) 1.26
Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Pain (1993) 1.26
Analgetic actions of intrathecal opiates in cat and primate. Brain Res (1978) 1.24
Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically induced neuropathic pain model in the rat. Reg Anesth (1997) 1.23
Cyclooxygenase inhibition and the spinal release of prostaglandin E2 and amino acids evoked by paw formalin injection: a microdialysis study in unanesthetized rats. J Neurosci (1995) 1.20
Antinociceptive effects of spinal cholinesterase inhibition and isobolographic analysis of the interaction with mu and alpha 2 receptor systems. Anesthesiology (1994) 1.19
Baclofen is antinociceptive in the spinal intrathecal space of animals. Eur J Pharmacol (1978) 1.19
Characterization of the pharmacology of intrathecally administered alpha-2 agonists and antagonists in rats. J Pharmacol Exp Ther (1992) 1.17
Antinociceptive effects of intrathecally injected cholinomimetic drugs in the rat and cat. Eur J Pharmacol (1985) 1.17
Spinal glial TLR4-mediated nociception and production of prostaglandin E(2) and TNF. Br J Pharmacol (2010) 1.16
Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action. Pharmacol Rev (1993) 1.16
Spinal monoamine and opiate systems partly mediate the antinociceptive effects produced by glutamate at brainstem sites. Brain Res (1984) 1.15
Importance of FSH-releasing protein and inhibin in erythrodifferentiation. Nature (1988) 1.15
Spinal serotonin terminal system mediates antinociception. J Pharmacol Exp Ther (1979) 1.15
Comparison of the antinociceptive effects of pre- and posttreatment with intrathecal morphine and MK801, an NMDA antagonist, on the formalin test in the rat. Anesthesiology (1992) 1.15
Genomic cloning of methylthioadenosine phosphorylase: a purine metabolic enzyme deficient in multiple different cancers. Proc Natl Acad Sci U S A (1996) 1.14
Spinal PKC activity and expression: role in tolerance produced by continuous spinal morphine infusion. Pain (2000) 1.14
Comparison of antinociceptive action of morphine in the periaqueductal gray, medial and paramedial medulla in rat. Brain Res (1986) 1.13
Ras activation in normal white blood cells and childhood acute lymphoblastic leukemia. Clin Cancer Res (2000) 1.12
Analgesic and neurotoxic effects of intrathecal corticosteroids in rats. Anesthesiology (1994) 1.12
An extensive exploration of the rat brain for sites mediating prostaglandin-induced hyperthermia. Brain Res (1977) 1.11
Selective stimulation of either tumor necrosis factor receptor differentially induces pain behavior in vivo and ectopic activity in sensory neurons in vitro. Neuroscience (2008) 1.11
Clinical significance of p53 mutations in relapsed T-cell acute lymphoblastic leukemia. Blood (1994) 1.11
Micturition in rats: a chronic model for study of bladder function and effect of anesthetics. Am J Physiol (1986) 1.10
Drug effects on urinary bladder tone during spinal morphine-induced inhibition of the micturition reflex in unanesthetized rats. Anesthesiology (1988) 1.10
Electrophysiological characteristics of primary afferent fibers after systemic administration of anti-GD2 ganglioside antibody. Pain (1997) 1.10
Epidural injections of bupivacaine, morphine, fentanyl, lofentanil, and DADL in chronically implanted rats: a pharmacologic and pathologic study. Anesthesiology (1986) 1.10
Multiple opioid receptor systems in brain and spinal cord: Part I. Eur J Anaesthesiol (1984) 1.10
Spinal noradrenergic terminal system mediates antinociception. Brain Res (1980) 1.10
Long-term pain relief produced by intrathecal morphine infusion in 53 patients. J Neurosurg (1990) 1.09
The role of NMDA and non-NMDA excitatory amino acid receptors in the excitation of primate spinothalamic tract neurons by mechanical, chemical, thermal, and electrical stimuli. J Neurosci (1992) 1.09
Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal gray. Brain Res (1979) 1.08
The pharmacokinetics of lignocaine in humans during a computer-controlled infusion. Eur J Pain (1997) 1.08
Sites of action of opiates in production of analgesia. Prog Brain Res (1988) 1.08
Intrathecal baclofen and muscimol, but not midazolam, are antinociceptive using the rat-formalin model. J Pharmacol Exp Ther (1995) 1.08
Properties of two unmyelinated fibre tracts of the central nervous system: lateral Lissauer tract, and parallel fibres of the cerebellum. J Physiol (1978) 1.07
Stereospecific effects of a nonpeptidic NK1 selective antagonist, CP-96,345: antinociception in the absence of motor dysfunction. Life Sci (1991) 1.06
Epidural ketamine: a useful, mechanistically novel adjuvant for epidural morphine? Reg Anesth (1997) 1.06
Studies on the antagonism by raphe lesions of the antinociceptive action of systemic morphine. Eur J Pharmacol (1977) 1.06
Characterization of muscarinic receptor subtypes that mediate antinociception in the rat spinal cord. Anesth Analg (1997) 1.06
Structure-antinociceptive activity of neurotensin and some novel analogues in the periaqueductal gray region of the brainstem. Brain Res (1991) 1.06
Development of GABA-sensitive spasticity and rigidity in rats after transient spinal cord ischemia: a qualitative and quantitative electrophysiological and histopathological study. Neuroscience (2006) 1.05
Antinociceptive properties of intrathecal dexmedetomidine in rats. Eur J Pharmacol (1991) 1.05
Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanoma. Hum Antibodies Hybridomas (1992) 1.05
The antinociceptive effects of spinally administered neuropeptide Y in the rat: systematic studies on structure-activity relationship. J Pharmacol Exp Ther (1991) 1.04
An improved method for chronic catheterization of the rat spinal subarachnoid space. Physiol Behav (1981) 1.04
The effect of morphine on formalin-evoked behaviour and spinal release of excitatory amino acids and prostaglandin E2 using microdialysis in conscious rats. Br J Pharmacol (1995) 1.03
Concentration-effect relations for intravenous lidocaine infusions in human volunteers: effects on acute sensory thresholds and capsaicin-evoked hyperpathia. Anesthesiology (1997) 1.03
Methylation of p16INK4A in primary gynecologic malignancy. Cancer Lett (1999) 1.03
Changes in body temperature of the unanaesthetized monkey produced by sodium and calcium ions perfused through the cerebral ventricles. J Physiol (1971) 1.02
Intrathecal substance P-induced thermal hyperalgesia and spinal release of prostaglandin E2 and amino acids. Neuroscience (1999) 1.02
Dynorphin A and related peptides administered intrathecally in the rat: a search for putative kappa opiate receptor activity. J Pharmacol Exp Ther (1986) 1.02
Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists. J Pharmacol Exp Ther (1996) 1.02
Vincristine-induced allodynia in the rat. Pain (2001) 1.02
Spinal pharmacology of thermal hyperesthesia induced by constriction injury of sciatic nerve. Excitatory amino acid antagonists. Pain (1992) 1.02
Pain models display differential sensitivity to Ca2+-permeable non-NMDA glutamate receptor antagonists. Anesthesiology (2001) 1.02